Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Ben Fischer, reporter at Sports Business Journal, speaks to Dave Briggs to unpack everything you need to know about the NFL's Sunday Night Ticket lawsuit.
A booming industry, THC beverages, is under regulatory attack. Legal via the 2018 Farm Bill, they're found in liquor stores and bars, not just dispensaries.